Welcome. If you're a registered user, please log-in. If not, please sign-up.

Veterinary Vaccines Conference

The INDUSTRY driven multidisciplinary veterinary vaccine event

Informa Life Sciences’ 6th Annual Veterinary Vaccines conference has been specifically designed to provide you with critical innovations for identifying and responding to emerging diseases and regulatory feedback for veterinary vaccine registerations. Plus the latest technological advances in adjuvants and delivery platforms including DNA vaccine, vector and recombinant vaccine from industry and academia to optimise your vaccine development programme. 

Who Should Attend? Heads of Department, Directors, Managers, Team Leaders, Associates and Consultants from:

  • Research and Development
  • Vaccine development/ Vaccine control
  • Regulatory Affairs
  • Vaccine Registration
  • Chief Science Officer
  • Veterinary Virology
  • Technology and Immunology
  • Clinicial Studies
  • Biologicals Department

This event is essential attendance for all professionals involved and working with:

  • GMO vaccine
  • DNA vaccine
  • Recombinant vaccine
  • Vector vaccine
  • Adjuvant
  • Protein purification
  • Immune response

 

Veterinary vaccine interactive seminars and workshops

Make the most out of your time out of the office by attending our additional Seminars and Workshops:

  • Pre-Conference Workshop: Tuesday 29 November 2011
    Practical Aspects of the Development and Registration of Veterinary Vaccines

    Workshop Leaders:
    Rhona Banks, Director Regulatory Affairs, Triveritas, UK
    Juliet Greenslade, Senior Scientific Consultant, Triveritas, UK

 

  • Evening Seminar, Discussion & Dinner: Wednesday 30 November 2011
    Exploring Antivirals in the Animal Health Industry

    Led by:
    Nesya Goris, Chief Scientist, Okapi Sciences NV, Belgium
    Philippe Hansen, Diplomat, European College of Veterinary Ophthalmologists (ECVO)
  • Post-Conference Workshop: Friday 2nd December 2011
    Best Practices for Manufacturing and Scale-Up of Veterinary Vaccines
     
    Led by: Patricio Massera, Operations Director, MSD AH, Spain
..

Sponsor

..
..
..
..

Spotlight Session Sponsor

..
..
..
..

Promotional Participant

..
..
..
..

Media Partners

..
..
..

Veterinary Vaccine Speakers 2011: 15 NEW Speakers for 2011

Veterinary Vaccine Speakers 2011: 15 NEW Speakers for 2011

Kristi Moore Dorsey, Vice President, R&D, CEVA BIOMUNE, USA

Stephane Lemiere, Avian Global Technical Director, Merial S.A.S. France

Peter Heegaard, Professor, Technical University of Denmark, Denmark

Habil Hansjörg Lehnherr, CSO, PTC Phage Technology Center GmbH, Germany

Practical experience from industry leaders at the front of veterinary vaccine development:
  • Catrina Stirling, Associate Director - Biological Regulatory Affairs, VMRD, Pfizer Ltd, UK
  • Caroline Noach, R&D Manager– Global Vaccines, Phibro Animal Health Corporation, Israel
  • Mercè Roca, Pre-Clinical Trials Coordinator, Laboratorios Hipra S.A., Spain
  • Barbara Domayne-Hayman, Chief Executive Officer, Stabilitech Ltd, UK

Key European regulators and government departments:

  • Alex Morrow,  Deputy Science Coordinator, Veterinary Science Team, DEFRA, UK
  • Peer Lyng Frandsen, Scientific Officer, Danish Medicines Agency, Denmark
  • Javier Martínez de Velasco, AEMP’s Designated Expert on GMOs and Immunological Products, Tragsatec, Spain

Leading academics presenting unbiased cutting edge vet vaccine research:

  • Roar Gudding, Deputy Director, National Veterinary Institute, Norway
  • Paul V Barnett, FMD Vaccine Group, Institute for Animal Health, UK 
  • Veronica Fowler, Post Doctoral Research Scientist: FMD Vaccine Group, Institute for Animal Health, UK
  • Eric Cox, Laboratory of Immunology, Faculty of Veterinary Medicine, UGent, Belgium



Feeds
rss
Like
Share
twitterfacebooklinkedinemail

Dates and Venues

30 Nov 2011 - 01 Dec 2011

Sheraton Brussels Hotel, Belgium

Latest Agenda Updates

Day 2: Thursday 1st December

11.55: A Broadly Applicable Vaccine Stabilisation Technology

  • Protects vaccines from heat and freeze damage
  • Enables longer term storage at ambient temperatures
  • Easily integrated into existing manufacturing processes using standard equipment
  • Case studies on stabilisation of viral vaccines
  • Case studies on stabilisation of recombinant proteins

Barbara Domayne-Hayman, Chief Executive Officer, Stabilitech Ltd, UK

Veterinary Vaccines 2010 Reviews

"Very focussed and informative presentations on veterinary vaccines. Very good networking"
Associate Director, Pfizer Animal Health, 2010
"Insightful and informative on regulatory and technology developments that will impact the industry in the future"
Strategy and Planning Executive, Onderstepoort Biological Products, 2010

Related Events

Download Latest Information Now

(updated 22 May 2012)


Bookmark and Share